| The Visceral Adiposity Measurement and Observation Study (NCT05383456) | Theratechnologies | 2022-04-18 |
| Effect of a Mobile Health Intervention on Treatment Adherence (NCT05187741) | Hospital Civil de Guadalajara | 2022-04-01 |
| Early Empiric Anti-Mycobacterium Tuberculosis Therapy for Sepsis in Sub-Saharan Africa (NCT04618198) | University of Virginia | 2021-12-10 |
| Neuroinflammation and Neurodegeneration in HIV-positive Subjects Switched and Initially Treated With INSTI (NCT04887675) | University of Novi Sad | 2021-05-01 |
| Intervention to Improve HIV Care Retention by Addressing Stigma Stigmatized Environments (NCT05110963) | University of Connecticut | 2021-02-01 |
| Assessing the Impact of INSTI to PI Switch on Insulin Sensitivity and Fat Metabolism (NCT04675255) | Washington University School of Medicine | 2021-01-01 |
| VIR-1111: A Prototype Human CMV-based Vaccine for Human Immunodeficiency Virus (HIV) in Healthy Volunteers (NCT04725877) | Vir Biotechnology, Inc. | 2020-12-28 |
| Efficacy of Switching to DTG/3TC in Virologically-suppressed Adults Currently on B/F/TAF (NCT04585737) | Charlotte-Paige Rolle, MD | 2020-10-05 |
| Acute Effects of TCIG vs ECIG in PLWH (NCT04568395) | University of California, Los Angeles | 2020-10-01 |
| Leveraging Family-Based Assets for Black MSM In House Ball Communities (NCT05071378) | State University of New York - Downstate Medical Center | 2020-09-17 |
| Access HIV Ag/Ab Combo Assay - European Union (EU) Clinical Trial Protocol (NCT04971343) | Beckman Coulter, Inc. | 2019-12-04 |
| Evaluation of Pre-Exposure Prophylaxis (PrEP) in Pregnant and Breastfeeding Women (NCT03902418) | University of California, Los Angeles | 2019-07-01 |
| Role of the IL33/Amphiregulin Pathway as a Potential Therapeutic Target in HIV Infection (NCT03622177) | ANRS, Emerging Infectious Diseases | 2018-09-01 |
| Charlotte Retention in Care Study (NCT03584048) | Epividian | 2018-07-01 |
| Community Based Antiretroviral Therapy (CBART) Among Children on Chronic ART (NCT03986099) | Biomedical Research and Training Institute, Zimbabwe | 2018-02-01 |
| Safety and Efficacy of Romidepsin and the Therapeutic Vaccine Vacc-4x for Reduction of the Latent HIV-1 Reservoir (NCT02092116) | Bionor Immuno AS | 2014-03-01 |
| Immunogenicity Study of Vacc-4x Versus Placebo in Patients Infected With HIV (NCT00659789) | Bionor Immuno AS | 2008-08-01 |